Emory cancer clinical trials

You can always stop participating in the clinical trial at any time. For more information on cancer clinical trials or research studies, ask your medical care provider or call or send an email to winshipcto emory. Types of Clinical Trials A clinical trial is a form of research that enlists participants to help answer specific questions about new ways to prevent, diagnose, and treat cancer. Clinical trials occur in three phases necessary for FDA approval of a new treatment option:. Phase I Clinical Trial: Phase I trials study whether a new treatment is safe to use over a range of doses.

Phase I Unit at Winship. PROS: Cancer clinical trials offer high-quality cancer care. In cancer clinical trials if you do not receive the new treatment being tested, you will receive the best standard treatment.

This may be as good as, or better than, the new approach. If a new treatment approach is proven to work and you are taking it, you may be among the first to benefit. By looking at the pros and cons of cancer clinical trials and your other treatment choices, you are taking an active role in a decision that affects your life.

You may have the chance to help others and improve cancer treatment. CONS: New treatments in cancer clinical trials are not always better than standard care. You may have side effects that medical care providers do not expect or that are worse than those of standard treatment. By downloading Emory news media, you agree to the following terms of use: Creative Commons Attribution-NoDerivatives 4. Section 1 — Definitions. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor.

For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

Licensor means the individual s or entity ies granting rights under this Public License. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning. Section 2 — Scope. License grant. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to: reproduce and Share the Licensed Material, in whole or in part; and produce and reproduce, but not Share, Adapted Material.

Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions. The term of this Public License is specified in Section 6 a. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so.

For purposes of this Public License, simply making modifications authorized by this Section 2 a 4 never produces Adapted Material. Downstream recipients. The focus of the CTO is to help develop and support institutional clinical research studies, particularly phase I and institutional studies.

In , the Phase I Clinical Trials Unit opened and is dedicated to advancing cancer research through a singular focus on caring for patients enrolled in phase I clinical trials. Additionally, support is provided at other area facilities where Emory investigators conduct clinical trials, including Atlanta VA Medical Center and Grady Memorial Hospital.

The CTO has supported clinical research from Emory University that has led to numerous publications since The CTO manages the overall process of subject screening, consent, registration, data entry and regulatory document submission and management for clinical research studies involving cancer patients.

To achieve the goals, the CTO pursues the following specific objectives:. The CTO is the central clearinghouse for the initiation and registration of clinical protocols involving cancer patients.

It is authorized by the executive director of the Winship Cancer Institute to:. The CTO has developed policies and procedures to facilitate centralized management of cancer clinical studies across all departments in which subjects may be enrolled on cancer clinical trials.

The CTO staff monitors study procedures to ensure regulatory compliance and provides regular instruction to new and current staff in these areas. The creation of these teams has stimulated greater interaction, communication and teamwork among the faculty and research staff facilitating clinical trials.